These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 12691305

  • 1. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
    Korycka A, Robak T.
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305
    [Abstract] [Full Text] [Related]

  • 2. The influence of amifostine used alone or in combination with 2-chlorodeoxyadenosine on normal and chronic myelogenous leukemia granulocyte-macrophage progenitor cells in vitro.
    Korycka A, Robak T.
    Arch Immunol Ther Exp (Warsz); 2000; 48(4):293-9. PubMed ID: 11059647
    [Abstract] [Full Text] [Related]

  • 3. The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.
    Korycka A, Robak T.
    Leuk Lymphoma; 2003 Sep; 44(9):1549-55. PubMed ID: 14565659
    [Abstract] [Full Text] [Related]

  • 4. The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro.
    Korycka A, Smolewski P, Robak T.
    Eur J Haematol; 2004 Dec; 73(6):418-26. PubMed ID: 15522064
    [Abstract] [Full Text] [Related]

  • 5. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R, Petzer AL, Zilian U, Geisen FH, Schirmer M, Haun M, Konwalinka G.
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [Abstract] [Full Text] [Related]

  • 6. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
    Robak T, Korycka A.
    Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
    [Abstract] [Full Text] [Related]

  • 7. Influence of gemcitabine (2',2'-difluoro-deoxycytidine) and 2-chlorodeoxyadenosine on growth of normal and leukemic cells in vitro.
    Lech-Marańda E, Korycka A, Robak T.
    Eur J Haematol; 2000 Nov; 65(5):317-21. PubMed ID: 11092462
    [Abstract] [Full Text] [Related]

  • 8. [Effect of 2-chlorodeoxyadenosine, arabinoside cytosine and doxorubicin on acute myeloid leukemia clonogenic cell proliferation].
    Sawiński K, Hansz J, Kozłowska-Skrzypczak M.
    Acta Haematol Pol; 1995 Nov; 26(3):279-84. PubMed ID: 8525773
    [Abstract] [Full Text] [Related]

  • 9. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M, Lishner M, Amiel A, Nagler A, Yarkorli S, Rudi A, Kashman Y, Markel D, Fabian I.
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [Abstract] [Full Text] [Related]

  • 10. Growth-inhibitory effect of 2-CdA on myeloid CFU-GM progenitors in normal human long-term bone marrow cultures and its compensation by G-CSF or IL-3.
    Petzer AL, Geisen FH, Bilgeri R, Zilian U, Haun M, Herold M, Braunsteiner H, Konwalinka G.
    Exp Hematol; 1995 Jun; 23(6):529-34. PubMed ID: 7539380
    [Abstract] [Full Text] [Related]

  • 11. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
    Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G.
    Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
    [Abstract] [Full Text] [Related]

  • 12. Suppression of chronic myelogenous leukemia colony growth by interleukin-4.
    Estrov Z, Markowitz AB, Kurzrock R, Wetzler M, Kantarjian HM, Ferrajoli A, Gutterman JU, Talpaz M.
    Leukemia; 1993 Feb; 7(2):214-20. PubMed ID: 8426475
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interferon protects normal human granulocyte/macrophage colony-forming cells from Ara-C cytotoxicity.
    Richman CM, Slapak CA, Toh B.
    J Biol Response Mod; 1990 Dec; 9(6):570-5. PubMed ID: 1705960
    [Abstract] [Full Text] [Related]

  • 16. Potent antileukemic activity of the novel agents norsegoline and dibezine.
    Einat M, Nagler A, Lishner M, Amiel A, Yarkoni S, Rudi A, Gellerman G, Kashman Y, Fabian I.
    Clin Cancer Res; 1995 Aug; 1(8):823-9. PubMed ID: 9816051
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A, Lambek C, Wisniewski D, Wachter M, Gulati SC, Clarkson BD.
    Cancer Res; 1988 Feb 15; 48(4):1035-41. PubMed ID: 3422181
    [Abstract] [Full Text] [Related]

  • 20. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
    Grant S, Traylor R, Bhalla K, McCrady C, Pettit GR.
    Leukemia; 1992 May 15; 6(5):432-9. PubMed ID: 1593908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.